Back to Search
Start Over
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.
- Source :
-
Nature communications [Nat Commun] 2024 Jan 03; Vol. 15 (1), pp. 225. Date of Electronic Publication: 2024 Jan 03. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 2041-1723
- Volume :
- 15
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Nature communications
- Accession number :
- 38172131
- Full Text :
- https://doi.org/10.1038/s41467-023-44575-3